FDA Inspection 1100903 — Atomvie Global Radiopharma Inc.
The FDA completed an inspection of Atomvie Global Radiopharma Inc. on Jul 19, 2019 in Hamilton. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 19, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Hamilton (Canada)